| __timestamp | Arrowhead Pharmaceuticals, Inc. | Axsome Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 24419536 | 1392830 |
| Thursday, January 1, 2015 | 34718089 | 2419289 |
| Friday, January 1, 2016 | 40998209 | 6343648 |
| Sunday, January 1, 2017 | 32022880 | 7206691 |
| Monday, January 1, 2018 | 19110051 | 9351522 |
| Tuesday, January 1, 2019 | 26556257 | 13598030 |
| Wednesday, January 1, 2020 | 52275890 | 28896749 |
| Friday, January 1, 2021 | 80981000 | 66646205 |
| Saturday, January 1, 2022 | 124431000 | 159253661 |
| Sunday, January 1, 2023 | 90932000 | 323123000 |
| Monday, January 1, 2024 | 98761000 |
Unleashing insights
In the competitive world of biotechnology, strategic spending on Selling, General, and Administrative (SG&A) expenses can be a key differentiator. Over the past decade, Arrowhead Pharmaceuticals, Inc. and Axsome Therapeutics, Inc. have demonstrated contrasting SG&A spending patterns.
Arrowhead Pharmaceuticals has shown a steady increase in SG&A expenses, peaking in 2022 with a 400% rise from 2014. This consistent growth reflects their strategic investments in administrative capabilities and market expansion. In contrast, Axsome Therapeutics experienced a dramatic surge in 2023, with SG&A expenses skyrocketing by over 23,000% since 2014. This spike suggests a significant shift in their operational strategy, possibly linked to new product launches or market penetration efforts.
Interestingly, while Arrowhead's 2024 data remains robust, Axsome's figures are missing, leaving room for speculation on their future financial strategies.
Selling, General, and Administrative Costs: Pfizer Inc. vs Axsome Therapeutics, Inc.
Vertex Pharmaceuticals Incorporated or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: GSK plc vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Genmab A/S and Axsome Therapeutics, Inc.
Dr. Reddy's Laboratories Limited and Arrowhead Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Cytokinetics, Incorporated and Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc. and Xenon Pharmaceuticals Inc.: SG&A Spending Patterns Compared
Axsome Therapeutics, Inc. and Catalyst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Amneal Pharmaceuticals, Inc. vs Arrowhead Pharmaceuticals, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Arrowhead Pharmaceuticals, Inc. or Novavax, Inc.
SG&A Efficiency Analysis: Comparing Arrowhead Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.